GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » Net Income (Continuing Operations)

Protia (XKRX:303360) Net Income (Continuing Operations) : ₩3,061 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Protia Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Protia's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ₩714 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩3,061 Mil.

Protia Net Income (Continuing Operations) Historical Data

The historical data trend for Protia's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protia Net Income (Continuing Operations) Chart

Protia Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations)
Get a 7-Day Free Trial -4,450.83 -771.79 1,252.82 462.94 2,442.12

Protia Quarterly Data
Dec18 Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.21 987.69 350.54 1,008.68 714.24

Protia Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,061 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protia  (XKRX:303360) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Protia Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Protia's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Protia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XKRX:221800 XKRX:086040 XKRX:246250 XKRX:229000 XKRX:109820 XKRX:031860 XKRX:363250 XKRX:950200 XKRX:122310 XKRX:236340 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
Room 702, Building A, 401 Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07528
Website
http://www.protia.co.kr
Protia Inc is a South Korean company engaged in research and development, manufacturing and sales of in vitro diagnostic medical devices and diagnostic reagents. Their main product is allergy diagnostic products for humans and animals,' as well as various immunochemical in vitro diagnostic products.

Protia Headlines

No Headlines